Biotech targeting rare forms of muscular dystrophy and cystic fibrosis.
Industry: Health Care
First Day Return: +9.9%
IPO Data | |
---|---|
IPO Date | 06/19/2013 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $126 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | South Plainfield, NJ, United States |
Founded | 1998 |
Employees at IPO | 127 |
Website www.ptcbio.com |